Nuveen Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,403
| Closed | -$768K | – | 3197 |
|
|
2022
Q3 | $768K | Buy |
3,403
+77
| +2% | +$17.4K | ﹤0.01% | 2849 |
|
|
2022
Q2 | $629K | Sell |
3,326
-493
| -13% | -$93.2K | ﹤0.01% | 2957 |
|
|
2022
Q1 | $990K | Sell |
3,819
-151
| -4% | -$39.1K | ﹤0.01% | 2822 |
|
|
2021
Q4 | $631K | Sell |
3,970
-428
| -10% | -$68K | ﹤0.01% | 3007 |
|
|
2021
Q3 | $952K | Buy |
4,398
+73
| +2% | +$15.8K | ﹤0.01% | 3003 |
|
|
2021
Q2 | $1.11M | Buy |
4,325
+594
| +16% | +$152K | ﹤0.01% | 2973 |
|
|
2021
Q1 | $991K | Sell |
3,731
-133
| -3% | -$35.3K | ﹤0.01% | 2887 |
|
|
2020
Q4 | $1.42M | Buy |
3,864
+655
| +20% | +$241K | ﹤0.01% | 2671 |
|
|
2020
Q3 | $783K | Buy |
3,209
+14
| +0.4% | +$3.42K | ﹤0.01% | 2793 |
|
|
2020
Q2 | $920K | Sell |
3,195
-4,627
| -59% | -$1.33M | ﹤0.01% | 2650 |
|
|
2020
Q1 | $1.6M | Buy |
7,822
+5,188
| +197% | +$1.06M | ﹤0.01% | 2295 |
|
|
2019
Q4 | $1.18M | Buy |
2,634
+645
| +32% | +$288K | ﹤0.01% | 2628 |
|
|
2019
Q3 | $611K | Sell |
1,989
-1,247
| -39% | -$383K | ﹤0.01% | 2882 |
|
|
2019
Q2 | $1.03M | Buy |
+3,236
| New | +$1.03M | ﹤0.01% | 2724 |
|